Dyax Corp. (NASDAQ: DYAX), a developer of novel biotherapeutics for unmet medical needs, announced today that Gustav A. Christensen, President and Chief Executive Officer of Dyax, will present at the Jefferies 2011 Global Healthcare Conference, being held June 6-9 2011 at the Grand Hyatt in New York City. Mr. Christensen will provide a corporate update regarding the Company’s three major business franchises and value drivers - KALBITOR® (ecallantide), the Licensing and Funded Research Program (LFRP) and the internal pipeline, including label expansion efforts with KALBITOR. The Dyax presentation is scheduled for Tuesday, June 7, 2011 at 9:00 AM ET.
